vs

Side-by-side financial comparison of HEARTLAND EXPRESS INC (HTLD) and Kiniksa Pharmaceuticals International, plc (KNSA). Click either name above to swap in a different company.

Kiniksa Pharmaceuticals International, plc is the larger business by last-quarter revenue ($202.1M vs $179.4M, roughly 1.1× HEARTLAND EXPRESS INC). Kiniksa Pharmaceuticals International, plc runs the higher net margin — 7.0% vs -10.8%, a 17.9% gap on every dollar of revenue. On growth, Kiniksa Pharmaceuticals International, plc posted the faster year-over-year revenue change (65.0% vs -26.1%). Kiniksa Pharmaceuticals International, plc produced more free cash flow last quarter ($53.3M vs $-44.2M). Over the past eight quarters, Kiniksa Pharmaceuticals International, plc's revenue compounded faster (59.1% CAGR vs -18.5%).

Heartland Express is an American trucking company headquartered in North Liberty, Iowa. The company offers truckload shipping services across the United States.

Kiniksa Pharmaceuticals International plc is a global biopharmaceutical firm focused on discovering, developing and commercializing targeted therapies for patients with unmet medical needs, primarily in autoimmune, inflammatory and rare disease segments. It operates across major markets including North America, Europe and Asia, advancing a pipeline of clinical-stage and approved treatment candidates.

HTLD vs KNSA — Head-to-Head

Bigger by revenue
KNSA
KNSA
1.1× larger
KNSA
$202.1M
$179.4M
HTLD
Growing faster (revenue YoY)
KNSA
KNSA
+91.0% gap
KNSA
65.0%
-26.1%
HTLD
Higher net margin
KNSA
KNSA
17.9% more per $
KNSA
7.0%
-10.8%
HTLD
More free cash flow
KNSA
KNSA
$97.5M more FCF
KNSA
$53.3M
$-44.2M
HTLD
Faster 2-yr revenue CAGR
KNSA
KNSA
Annualised
KNSA
59.1%
-18.5%
HTLD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HTLD
HTLD
KNSA
KNSA
Revenue
$179.4M
$202.1M
Net Profit
$-19.4M
$14.2M
Gross Margin
89.6%
Operating Margin
-12.7%
9.8%
Net Margin
-10.8%
7.0%
Revenue YoY
-26.1%
65.0%
Net Profit YoY
-949.2%
259.8%
EPS (diluted)
$-0.24
$0.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HTLD
HTLD
KNSA
KNSA
Q4 25
$179.4M
$202.1M
Q3 25
$196.5M
$180.9M
Q2 25
$210.4M
$156.8M
Q1 25
$219.4M
$137.8M
Q4 24
$242.6M
$122.5M
Q3 24
$259.9M
$112.2M
Q2 24
$274.8M
$108.6M
Q1 24
$270.3M
$79.9M
Net Profit
HTLD
HTLD
KNSA
KNSA
Q4 25
$-19.4M
$14.2M
Q3 25
$-8.3M
$18.4M
Q2 25
$-10.9M
$17.8M
Q1 25
$-13.9M
$8.5M
Q4 24
$-1.9M
$-8.9M
Q3 24
$-9.3M
$-12.7M
Q2 24
$-3.5M
$-3.9M
Q1 24
$-15.1M
$-17.7M
Gross Margin
HTLD
HTLD
KNSA
KNSA
Q4 25
89.6%
Q3 25
88.8%
Q2 25
88.1%
Q1 25
87.0%
Q4 24
85.4%
Q3 24
82.1%
Q2 24
88.7%
Q1 24
86.7%
Operating Margin
HTLD
HTLD
KNSA
KNSA
Q4 25
-12.7%
9.8%
Q3 25
-3.7%
13.3%
Q2 25
-5.9%
12.9%
Q1 25
-6.8%
9.6%
Q4 24
0.4%
-15.7%
Q3 24
-2.7%
-8.6%
Q2 24
0.1%
-0.1%
Q1 24
-5.3%
-20.7%
Net Margin
HTLD
HTLD
KNSA
KNSA
Q4 25
-10.8%
7.0%
Q3 25
-4.2%
10.2%
Q2 25
-5.2%
11.4%
Q1 25
-6.3%
6.2%
Q4 24
-0.8%
-7.3%
Q3 24
-3.6%
-11.3%
Q2 24
-1.3%
-3.6%
Q1 24
-5.6%
-22.2%
EPS (diluted)
HTLD
HTLD
KNSA
KNSA
Q4 25
$-0.24
$0.18
Q3 25
$-0.11
$0.23
Q2 25
$-0.14
$0.23
Q1 25
$-0.18
$0.11
Q4 24
$-0.03
$-0.11
Q3 24
$-0.12
$-0.18
Q2 24
$-0.04
$-0.06
Q1 24
$-0.19
$-0.25

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HTLD
HTLD
KNSA
KNSA
Cash + ST InvestmentsLiquidity on hand
$18.5M
$414.1M
Total DebtLower is stronger
$154.1M
Stockholders' EquityBook value
$755.3M
$567.6M
Total Assets
$1.2B
$763.6M
Debt / EquityLower = less leverage
0.20×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HTLD
HTLD
KNSA
KNSA
Q4 25
$18.5M
$414.1M
Q3 25
$32.7M
$352.1M
Q2 25
$22.9M
$307.8M
Q1 25
$23.9M
$268.3M
Q4 24
$12.8M
$243.6M
Q3 24
$30.7M
$223.8M
Q2 24
$23.9M
$218.8M
Q1 24
$23.8M
$213.6M
Total Debt
HTLD
HTLD
KNSA
KNSA
Q4 25
$154.1M
Q3 25
Q2 25
Q1 25
Q4 24
$187.9M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
HTLD
HTLD
KNSA
KNSA
Q4 25
$755.3M
$567.6M
Q3 25
$775.6M
$535.4M
Q2 25
$786.7M
$495.0M
Q1 25
$807.7M
$457.5M
Q4 24
$822.6M
$438.4M
Q3 24
$825.7M
$437.0M
Q2 24
$836.8M
$435.1M
Q1 24
$848.8M
$431.9M
Total Assets
HTLD
HTLD
KNSA
KNSA
Q4 25
$1.2B
$763.6M
Q3 25
$1.3B
$712.3M
Q2 25
$1.3B
$661.1M
Q1 25
$1.3B
$599.3M
Q4 24
$1.3B
$580.6M
Q3 24
$1.4B
$555.3M
Q2 24
$1.4B
$542.4M
Q1 24
$1.5B
$519.7M
Debt / Equity
HTLD
HTLD
KNSA
KNSA
Q4 25
0.20×
Q3 25
Q2 25
Q1 25
Q4 24
0.23×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HTLD
HTLD
KNSA
KNSA
Operating Cash FlowLast quarter
$14.9M
$53.9M
Free Cash FlowOCF − Capex
$-44.2M
$53.3M
FCF MarginFCF / Revenue
-24.6%
26.4%
Capex IntensityCapex / Revenue
33.0%
0.3%
Cash ConversionOCF / Net Profit
3.80×
TTM Free Cash FlowTrailing 4 quarters
$-66.9M
$136.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HTLD
HTLD
KNSA
KNSA
Q4 25
$14.9M
$53.9M
Q3 25
$27.5M
$33.7M
Q2 25
$21.0M
$28.1M
Q1 25
$25.8M
$22.3M
Q4 24
$37.8M
$18.8M
Q3 24
$35.6M
$-2.2M
Q2 24
$40.0M
$5.2M
Q1 24
$31.0M
$4.0M
Free Cash Flow
HTLD
HTLD
KNSA
KNSA
Q4 25
$-44.2M
$53.3M
Q3 25
$-12.2M
$33.0M
Q2 25
$-12.8M
$27.9M
Q1 25
$2.3M
$22.2M
Q4 24
$-45.5M
$18.6M
Q3 24
$24.6M
Q2 24
$29.4M
Q1 24
$26.3M
$3.9M
FCF Margin
HTLD
HTLD
KNSA
KNSA
Q4 25
-24.6%
26.4%
Q3 25
-6.2%
18.2%
Q2 25
-6.1%
17.8%
Q1 25
1.0%
16.1%
Q4 24
-18.8%
15.2%
Q3 24
9.5%
Q2 24
10.7%
Q1 24
9.7%
4.9%
Capex Intensity
HTLD
HTLD
KNSA
KNSA
Q4 25
33.0%
0.3%
Q3 25
20.2%
0.4%
Q2 25
16.1%
0.1%
Q1 25
10.7%
0.1%
Q4 24
34.3%
0.2%
Q3 24
4.2%
0.0%
Q2 24
3.8%
0.0%
Q1 24
1.7%
0.1%
Cash Conversion
HTLD
HTLD
KNSA
KNSA
Q4 25
3.80×
Q3 25
1.83×
Q2 25
1.58×
Q1 25
2.61×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons